GIT microbiota and mitochondrial crosstalk appears to occur primarily via complex endocrine, humoural and immune pathway signalling.
Researchers are finding that different gut microbes can even influence the way medicines work in our bodies. The problem is that it’s both good and bad news. But what all of the research points to is that we’d better look after our microbes.
Recent studies have observed differences in the local breast microbiome of subjects with malignant breast cancer compared to those with benign tumours or who were disease-free.
Looking at the complex interplay of exogenous and endogenous toxicity and the gut microbiota.
SIBO causes inflammation both in the gut and systemically and is notoriously difficult to treat, with high relapse rates, so finding new treatment protocols for SIBO is hugely beneficial.
